|
Real-time Estimate
Cboe BZX
19:09:53 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 22.60 USD | -1.93% |
|
+2.31% | +27.83% |
| 10-27 | Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading | MT |
| 10-26 | Zai Lab's Lung Cancer Drug Achieves Promising Response Rate in Phase 1b Trial; Shares up 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | -2.19% | +2.31% | +27.83% | -10.94% | -78.40% | 2.59B |  |  | |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
